CLINICAL_TRIALS
trial_result
· 2017-06-28
Clinical Trial Update: A Short Treatment Study of Aripiprazole in Pediatric Patients With Schizophrenia [Phase 2, Phase 3]
Summary
A Phase 2/3 clinical trial update on aripiprazole in pediatric patients with schizophrenia. The study has completed and results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Schizophrenia | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-06-28